Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $25.07, with a market capitalization of 143.14B. The stock trades at a price-to-earnings (P/E) ratio of 19.18 and offers a dividend yield of 6.88%.
On 2026-08-04, Pfizer(PFE) stock traded between a low of $24.86 and a high of $25.26. Shares are currently priced at $25.07, which is +0.8% above the low and -0.8% below the high.
The Pfizer(PFE)'s current trading volume is 769.01K, compared to an average daily volume of 36.95M.
During the past year, Pfizer(PFE) stock moved between $23.40 at its lowest and $28.75 at its peak.
During the past year, Pfizer(PFE) stock moved between $23.40 at its lowest and $28.75 at its peak.
PFE News
Pfizer (NYSE: PFE) reported second-quarter results that topped Wall Street expectations and raised its full-year revenue outlook, driven by stronger-than-expect...
Pfizer swung to a second-quarter loss. angela weiss / Agence France-Presse / Getty Images Pfizer PFE 0.08 %increase; up pointing triangle swung to a second-qua...
Pfizer Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, March 4, 2026. Pfizer on Tuesday reported second-quarter...
Analyst ratings
62%
of 29 ratingsMore PFE News
Reports Q2 revenue $15B, consensus $14.39B. “Pfizer (PFE) had another strong quarter, delivering on our financial commitments and advancing our strategy. Our la...
Pfizer Inc. (NYSE:PFE) will release its second quarter earnings report before the opening bell on Tuesday, Aug. 4. Analysts expect the New York-based company t...
Key Points Pfizer has consistently been paying its shareholders a dividend for decades. The company has also carefully raised its dividend, ensuring the payou...
Healthcare giants Pfizer (PFE) and Merck (MRK) are scheduled to report their quarterly earnings on Tuesday, with analysts expecting a decline in their bottom li...
AI in healthcare sits at the crossroads of powerful trends that matter for investors, from aging populations and rising treatment costs to central banks wrestli...
Key Points Pfizer's financial results haven't been great, and upcoming patent cliffs could exacerbate the problem. However, the company's large pipeline acros...
In late July 2026, Pfizer reported positive Phase 3 results for its oral JAK3/TEC inhibitor LITFULO in nonsegmental vitiligo and secured European Commission app...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.